Rapport Therapeutics RAPP
NASDAQ RAPP
$25.06 -4.31 (-14.67%)
At close: Oct 21, 2026 · 4:00 PM EDT

Rapport Therapeutics (RAPP) Other financing activities (2023 - 2026)

Updated

Rapport Therapeutics' Other financing activities was $181,000 in Q2 2026, up 187.3% from $63,000 a year earlier but down 33.7% from the prior quarter.

Analysis

Rapport Therapeutics (RAPP) Other financing activities (2023 - 2026) Analysis & Trends

On a trailing twelve-month basis, Rapport Therapeutics' Other financing activities was $517,000 through Jun 30, 2026; for FY2023, it came in at $134,000.

  • Quarterly Other financing activities has moved between $63,000 (Q2 2025) and $283,000 (Q1 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Rapport Therapeutics 1.19 Bn 367.93 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -181,000.00
Mar 31, 2026 -278,000.00
Sep 30, 2025 63,000.00
Jun 30, 2025 -63,000.00
Mar 31, 2025 -1,000.00
Jun 30, 2024 -16.82 Mn
Mar 31, 2024 -283,000.00
Dec 31, 2023 -134,000.00
Sep 30, 2023 62,000.00
Jun 30, 2023 29,000.00
API Access

Rapport Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=RAPP&period=max&api_key=YOUR_API_KEY